• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Carlyle

Manufacturing

CDMO Piramal earmarks $74M for upgrades to UK facilities

Piramal Pharma will spend $74.4 million to expand its antibody-drug conjugate (ADC) and API manufacturing facilities in the U.K.
Joseph Keenan Feb 8, 2022 9:55am

Investor groups size up $25B bid for Sandoz: report

Feb 1, 2022 11:04am

Vectura at center of tug-of-war between Carlyle, Philip Morris

Aug 11, 2021 9:24am

Vectura has a new bidder in Marlboro maker Philip Morris

Jul 9, 2021 8:12am

Carlyle is buying British inhaled meds CDMO Vectura for $1.4B

May 26, 2021 8:57am

Piramal continues expansion with $105M acquisition of Hemmo

Apr 1, 2021 10:55am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy